Bradley Birkenfeld just got some good news and some bad news. The good news was that he got a $104 million payment from the IRS for his role in catching tax evaders. The bad news: His reward isn't tax exempt.
Everyone knows Johnson & Johnson, but not everyone knows how big this pharmaceutical and medical device giant really is. And they also may not realize how much it's recent series of drug recalls and management missteps have pummeled the blue chip stock.